| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 15th September 2020 | Advisors Llc Orbimed | 292,607 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Advisors Llc Orbimed | 902,885 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Carl L Gordon | 902,885 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Advisors Llc Orbimed | 4,822,960 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Carl L Gordon | 4,822,960 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Carl L Gordon | 292,607 | Grant/award etc. | $0.00 | |
| 18th August 2020 | Advisors Llc Orbimed | 43,543 | Open or private sale | $108.54 | $4,726,157.22 |
| 17th August 2020 | Advisors Llc Orbimed | 94,900 | Open or private sale | $107.49 | $10,200,801.00 |
| 14th August 2020 | Advisors Llc Orbimed | 20,257 | Open or private sale | $109.03 | $2,208,620.71 |
| 13th August 2020 | Advisors Llc Orbimed | 29,251 | Open or private sale | $109.93 | $3,215,562.43 |
Prevail Therapeutics
Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.
Ticker: PRVL
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1714798
Employees: 55
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
These restaurants have filed for bankruptcy and many more are at risk
23rd September 2020
Nike swings back to a quarterly profit as digital sales surge 82%
22nd September 2020
Japanese fashionista aiming to put Filipino kids on runway to success
22nd September 2020
BlackRock, JPMorgan climate votes at odds as new rules loom
22nd September 2020
